Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)

Clinical trial NCT00952341 · COMPLETED

Trial details

NCT number: NCT00952341
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting (CINV)

Start date: 2009-08-25
Primary completion: 2010-04-04
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.